A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007) (NCT07677163)
A Clinical Study to Evaluate the Relative Bioavailability of MK-1403 Formulations Administered to Healthy Adult Participants
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD). Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.
Who can join: Review the eligibility criteria below.
Location: Qps-Mra, Llc โ Miami, Florida
Age range: 18 Years to 55 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Qps-Mra, Llc โ Miami, Florida
๐ Contact the Study Coordinator
Phone: (888) 577-8839
Email: Trialsites@msd.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Healthy
- Xanthohumol Metabolism and Signature โ Portland, Oregon
- Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being โ Stanford, California
- A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions โ Detroit, Michigan
- A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) โ Hollywood, Florida
- Pediatric Parenting Support in Flint โ Flint, Michigan
- Biomarker-estimated Flavanol Intake in Davis (FID) โ Davis, California
Explore by condition: All Healthy clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.